Citations are updated once a week. Recently added citations may not appear.
Context | Citation |
---|---|
Pediococcus |
?
Reversion of Gut Microbiota during the Recovery Phase in Patients with Asymptomatic or Mild COVID-19: Longitudinal Study. Microorganisms (Microorganisms ) Vol: 9 Issue 6 Pages: Pub: 2021 Jun 7 Epub: 2021 Jun 7 Authors Kim HN , Joo EJ , Lee CW , Ahn KS , Kim HL , Park DI , Park SK , Html Article Publication |
Pediococcus |
?
Impact of Mediterranean Diet on Disease Activity and Gut Microbiota Composition of Rheumatoid Arthritis Patients. Microorganisms (Microorganisms ) Vol: 8 Issue 12 Pages: Pub: 2020 Dec 14 Epub: 2020 Dec 14 Authors Picchianti Diamanti A , Panebianco C , Salerno G , Di Rosa R , Salemi S , Sorgi ML , Meneguzzi G , Mariani MB , Rai A , Iacono D , Sesti G , Pazienza V , Laganà B , Html Article Publication |
Pediococcus |
?
Thyroid-Gut-Axis: How Does the Microbiota Influence Thyroid Function? Nutrients (Nutrients ) Vol: 12 Issue 6 Pages: Pub: 2020 Jun 12 Epub: 2020 Jun 12 Authors Knezevic J , Starchl C , Tmava Berisha A , Amrein K , Html Article Publication |
Pediococcus |
?
2`-fucosyllactose Supplementation Improves Gut-Brain Signaling and Diet-Induced Obese Phenotype and Changes the Gut Microbiota in High Fat-Fed Mice. Nutrients (Nutrients ) Vol: 12 Issue 4 Pages: Pub: 2020 Apr 5 Epub: 2020 Apr 5 Authors Lee S , Goodson M , Vang W , Kalanetra K , Barile D , Raybould H , Html Article Publication |
Pediococcus |
?
Immunomodulatory and Prebiotic Effects of 2`-Fucosyllactose in Suckling Rats. Frontiers in immunology (Front Immunol ) Vol: 10 Issue Pages: 1773 Pub: 2019 Epub: 2019 Jul 31 Authors Azagra-Boronat I , Massot-Cladera M , Mayneris-Perxachs J , Knipping K , Van`t Land B , Tims S , Stahl B , Garssen J , Franch À , Castell M , Rodríguez-Lagunas MJ , Pérez-Cano FJ , Html Article Publication |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.